Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/26/2025

Risk Factors for Obstructive Sleep Apnea

Major Risk Factors

  • Obesity is the principal risk factor for obstructive sleep apnea (OSA), with approximately 70% of OSA patients being obese and 40% of obese individuals having sleep apnea, according to the British Journal of Pharmacology 1
  • Body Mass Index (BMI) > 30 kg/m² significantly increases OSA risk, as stated by the American Academy of Sleep Medicine 2
  • Increased neck circumference (>17 inches in men, >16 inches in women) is a strong predictor of OSA, even in individuals with normal BMI, as reported by the American Academy of Sleep Medicine 2
  • A 10% increase in body weight is associated with a six-fold increase in odds ratio for developing OSA, according to the European Respiratory Journal 3, 4
  • Upper airway abnormalities that narrow the pharyngeal lumen increase OSA risk, as stated by the American Academy of Sleep Medicine 2
  • Male sex - OSA is more prevalent in men (24%) than women (9%), as reported by the American Society of Anesthesiologists 5
  • Age - incidence increases between ages 40-65 years, according to the European Respiratory Journal 3, 4
  • Postmenopausal status in women significantly increases risk compared to premenopausal women, as stated by the American Geriatrics Society 6
  • Alcohol consumption before sleep can worsen OSA by relaxing upper airway muscles, as reported by the American Geriatrics Society 6
  • Opioids worsen sleep apnea by depressing respiratory rate and depth, reducing upper airway patency, blunting respiratory responsiveness to carbon dioxide and hypoxia, and causing relaxation of tongue and upper airway muscles, as stated by the British Journal of Pharmacology 1, 5, 7
  • Testosterone therapy can worsen OSA, consistent with the higher prevalence in men, according to the British Journal of Pharmacology 1
  • Medications that induce weight gain can trigger or exacerbate OSA, including atypical antipsychotics, certain antidepressants, anticonvulsants, antidiabetic drugs, antihistamines, and beta and alpha-adrenergic blockers, as reported by the British Journal of Pharmacology 1, 7

Medical Comorbidities

  • Cardiovascular conditions associated with increased OSA risk, including heart failure, atrial fibrillation, treatment-refractory hypertension, and stroke, as stated by the American Academy of Sleep Medicine and the American Geriatrics Society 2, 6
  • Endocrine disorders, such as type 2 diabetes and hypothyroidism, increase OSA risk, as reported by the American Geriatrics Society and the American Academy of Sleep Medicine 2, 6

Progression Factors

  • Weight gain is the primary risk factor for progression of OSA across all age groups, according to the European Respiratory Journal 4
  • Even in patients with mild to moderate OSA, progression of disease severity has been demonstrated independent of BMI changes, as reported by the European Respiratory Journal 3, 4

Prevention Strategies

  • Weight management is the most effective preventive measure for OSA in overweight and obese individuals, as recommended by the American Thoracic Society 8
  • The American Thoracic Society strongly recommends comprehensive lifestyle intervention consisting of reduced-calorie diet, exercise or increased physical activity, and behavioral guidance, to prevent OSA 8

Weight Loss in Patients with Obstructive Sleep Apnea

Mechanisms and Interventions

  • Excessive daytime sleepiness, a symptom of OSA, severely limits patients' ability to engage in regular exercise and increased physical activity, with fatigue and reduced energy expenditure making it difficult to maintain the exercise component essential for comprehensive weight loss programs, as recommended by the American Thoracic Society 9, 10
  • Comprehensive lifestyle intervention programs, combining reduced-calorie diet, exercise/increased physical activity, and behavioral counseling, produce weight loss of approximately 8 kg at 6-12 months, significantly greater than usual care, with the American Thoracic Society providing a strong recommendation for all patients with OSA who have BMI ≥25 kg/m² to participate in such programs 9, 10, 11
  • High-intensity interventions (>14 visits over 6 months) produce greater weight loss than moderate or low-intensity programs, with self-monitoring, problem-solving, stimulus control, and relapse prevention strategies being essential, as supported by the American Thoracic Society 10
  • Meal substitution programs are particularly effective, producing weight loss of 11.6 kg with corresponding BMI reduction of 4.1 kg/m², as recommended by the American Thoracic Society 10
  • For patients with OSA and BMI ≥27 kg/m² whose weight has not improved despite comprehensive lifestyle intervention, the American Thoracic Society recommends evaluation for anti-obesity pharmacotherapy, with liraglutide decreasing body weight by 4.9 kg, BMI by 1.6 kg/m², and AHI by 6.1 events/hour over 32 weeks in patients with moderate-to-severe OSA 9
  • Weight loss interventions improve multiple outcomes, including reduction in daytime sleepiness, improved quality of life, symptom reduction, cardiometabolic improvements, and reduced neck circumference, with the American Thoracic Society recommending aggressive, comprehensive lifestyle intervention to address all three components (diet, exercise, behavioral counseling) simultaneously with OSA treatment 9

Lifestyle Measures to Reduce OSA

Core Components of Effective Lifestyle Intervention

  • The American Thoracic Society recommends a comprehensive lifestyle intervention program that combines reduced-calorie diet, exercise/increased physical activity, and behavioral counseling for overweight or obese adults with OSA, as it is superior to diet or exercise alone and directly reduces OSA severity, symptoms, and may eliminate the need for CPAP 12, 13
  • Meal substitution programs are particularly effective, producing weight loss of 11.6 kg with corresponding BMI reduction of geil reduction of 4.1 kg/m², which translates to meaningful reductions in apnea-hypopnea index (AHI) 12
  • Dietary interventions without meal substitution show minimal weight loss (only 0.8 kg), whereas those including meal substitution achieve substantial weight loss (11.6 kg) 12
  • Exercise is essential—interventions including exercise produce 9.0 kg weight loss and 3.2 kg/m² BMI reduction, whereas those without exercise show no significant weight loss 13
  • Comprehensive lifestyle interventions reduce AHI by 8.5 events/hour on average, with some studies showing reductions of 21-27 events/hour 12
  • Daytime sleepiness (Epworth Sleepiness Scale) improves by 2.4 points on average 12
  • Snoring, neck circumference (reduced by 1.3 cm), and oxygen desaturation index all improve significantly 12

Expected Clinical Outcomes

  • The American Thoracic Society provides a strong recommendation for comprehensive lifestyle intervention in all OSA patients with BMI ≥25 kg/m², though the certainty of evidence is very low due to heterogeneity in study designs 12, 13

REFERENCES

2

clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2009

3
4